Literature DB >> 4097852

Histochemistry of adrenal bodies in Parkinson's disease.

W A den Jager.   

Abstract

Entities:  

Mesh:

Year:  1970        PMID: 4097852     DOI: 10.1001/archneur.1970.00480300050006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  11 in total

1.  Noradrenaline, adrenaline and tyrosine hydroxylase in adrenal medulla from parkinsonian patients.

Authors:  P Cervera; O Rascol; A Ploska; G Gaillard; R Raisman; C Duyckaerts; J J Hauw; D Scherman; J L Montastruc; F Javoy-Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-08       Impact factor: 10.154

2.  Huntington's chorea and the adrenal.

Authors:  G W Bruyn; F H de Yong; J H van der Molen
Journal:  Br Med J       Date:  1972-02-19

3.  Neuropathology of the locus ceruleus: a semi-quantitative study.

Authors:  M Tomonaga
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

4.  Element analysis of Lewy and adrenal bodies in Parkinson's disease by electron probe microanalysis.

Authors:  Y Kimula; M Utsuyama; M Yoshimura; M Tomonaga
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

5.  Transient supression by stress of haloperidol induced catalepsy by the activation of the adrenal medulla.

Authors:  O P Yntema; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Glucocorticoids attenuate haloperidol-induced catalepsy through adrenal catecholamines.

Authors:  C T Chopde; M S Hote; S N Mandhane; A V Muthal
Journal:  J Neural Transm Gen Sect       Date:  1995

7.  Assessment of autonomic function in patients with a Parkinsonian syndrome.

Authors:  M J Aminoff; C S Wilcox
Journal:  Br Med J       Date:  1971-10-09

8.  Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study.

Authors:  J Vardi; H Glaubman; J M Rabey; M Streifler
Journal:  J Neurol       Date:  1978-04-14       Impact factor: 4.849

9.  Plasma dopamine beta hydroxylase (D.B.H.) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading.

Authors:  J Vardi; S Flechter; Z Oberman; M Allelov; J M Rabey; M Hertzberg; M Streifler
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

Review 10.  Neuronal vulnerability, pathogenesis, and Parkinson's disease.

Authors:  David Sulzer; D James Surmeier
Journal:  Mov Disord       Date:  2012-07-12       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.